Publication Name	World Journal of Gastroenterology
Manuscript ID	7741
Country	Australia

Received	2013-11-30 12:24
Peer-Review Started	2013-11-30 21:07
To Make the First Decision	2014-01-15 19:41
Return for Revision	2014-01-20 19:25
Revised	2014-02-15 21:29
Second Decision	2014-03-19 13:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-19 15:19
Articles in Press	2014-05-23 09:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-12 13:56
Publish the Manuscript Online	2014-06-27 10:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Personalising pancreas cancer treatment: When tissue is the issue
Manuscript Source	Invited Manuscript
All Author List	Katrin M Sjoquist, Venessa T Chin, Lorraine A Chantrill, Chelsie O’Connor, Chris Hemmings, David K Chang, Angela Chou, Marina Pajic, Amber L Johns, Adnan M Nagrial, Andrew V Biankin and Desmond Yip
Funding Agency and Grant Number	Funding Agency Grant Number NHMRC, Pancare Australia, Sydney Catalyst, Royal Australasian College of Physicians to Chin VT NHMRC Programme to Sjoquist KM
Corresponding Author	Desmond Yip, Associate Professor, Clinical Director, Department of Medical Oncology, The Canberra Hospital, Yamba Drive, Garran ACT 2605, Australia. desmond.yip@anu.edu.au
Key Words	Pancreatic neoplasms; Molecular targeted therapy; Genomics; Tissue banks; Chemotherapy
Core Tip	State of art review of genomic developments in pancreatic cancer that will hopefully lead to a new treatment paradigm of recognising that pancreatic cancer is a heterogenous disease. Adequate tissue collection is important to allow biomarker testing and molecular sequencing to allow determination of actionable mutations so that personalised therapies can be used in a rational manner.
Publish Date	2014-06-27 10:37
Citation	Sjoquist KM, Chin VT, Chantrill LA, O’Connor C, Hemmings C, Chang DK, Chou A, Pajic M, Johns AL, Nagrial AM, Biankin AV, Yip D. Personalising pancreas cancer treatment: When tissue is the issue. World J Gastroenterol 2014; 20(24): 7849-7863
URL	http://www.wjgnet.com/1007-9327/full/v20/i24/7849.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i24.7849

Full Article (PDF)	WJG-20-7849.pdf
Full Article (Word)	WJG-20-7849.doc
Manuscript File	7741-Review.doc
Answering Reviewers	7741-Answering reviewers.pdf
Copyright License Agreement	7741-Copyright assignment.pdf
Peer-review Report	7741-Peer reviewer(s).pdf
Scientific Editor Work List	7741-Scientific editor work list.doc